Navigation Links
Young adults with autism found to have difficulty transitioning into employment
Date:9/5/2013

Washington D.C. -- A study published in the September 2013 issue of the Journal of the American Academy of Child and Adolescent Psychiatry found that young adults with an autism spectrum disorder (ASD) have more difficulty transitioning into employment than their peers with different disabilities.

Using data from the National Longitudinal Transition Study 2 (NLTS2; a longitudinal nationally-representative survey of youth ages 13-16 years as of December 2000 and receiving special education services), a group of researchers led by Dr. Paul Shattuck of Washington University in St. Louis examined the employment outcomes of 620 young adults, ages 21-25 years, who previously received special education services in secondary school under the autism eligibility category. Employment outcomes for young adults with an ASD were compared to outcomes for similar-aged young adults with different disabilities, such as mental retardation, learning disabilities, emotional disturbance, and speech/language impairment.

The study found that only half (53%) of young adults with an ASD had ever worked for pay outside the home in the first 8 years following high school, the lowest rate among disability groups even when controlling for impairment severity, household income, and social demographics. Only 34% were employed at the time of the survey interview. One in five worked full-time with average earnings of $8.10/hour, significantly lower than disability comparison groups. Young adults with an ASD were most frequently employed in office and administrative support occupations and experienced less variation in job types than young adults with other disabilities. Outcomes were better for those who were older, from higher income households, or who had higher functional skills.

Study author, Ms. Anne Roux, said, "The news is mixed. The study confirms low rates of employment for young adults with an ASD using a large, national sample. It highlights the mark
'/>"/>

Contact: Jordi van de Weerd
j.weerd@elsevier.com
Elsevier
Source:Eurekalert

Page: 1 2

Related biology news :

1. 1 pill can kill: Effects of unintentional opioid exposure in young children
2. Vigorous physical activity linked to lower incidence of obesity in young African-American women
3. Soft drinks and behavioral problems in young children
4. Perception of fertility affects quality of life in young, female cancer survivors
5. Young beer-drinkers binge-drink more frequently
6. Flow restrictors may reduce young childrens accidental ingestion of liquid medications
7. Bert L. & N. Kuggie Vallee Foundation announces first recipients of its Young Investigator Awards
8. Damon Runyon Cancer Research Foundation awards $3.6 M to 9 top young clinical investigators
9. Changing ocean temperatures, circulation patterns affecting young Atlantic cod food supply
10. New data on islet autoantibodies in young children defines early type 1 diabetes development
11. Flu vaccines aimed at younger populations could break annual transmission cycle
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2015)... NEW YORK , June 24, 2015 ... favorable rate. The major drivers for the market include ... increasing number of new drug launches. Over the years, ... has increased. Between 2001 and 2010, the FDA approved ... addition, according to WIPO, Europe ...
(Date:6/24/2015)... Research and Markets( ... "Huawei Ascend Mate 7 Fingerprint Sensor - ... Huawei,s technological choice for the fingerprint ... Apple,s and Samsung,s one. The Ascend Mate 7 ... Cards, a main actor in capacitive sensing human ...
(Date:6/23/2015)... 2015 Research and ... the "Body-Worn Temperature Sensors Market - Global ... 2014 - 2020" report to their offering. ... the global body-worn temperature sensors market. The global ... the basis of types, care setting, patient demographic, ...
Breaking Biology News(10 mins):Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2Body-Worn Temperature Sensors Market - Global Industry Analysis 2
... major study sheds new light on the role of carbon ... indicates that instead of sinking, carbon dioxide is often consumed ... a dimly lit area 100 to 1,000 meters below the ... where it can be stored and prevented from re-entering the ...
... from preterm birth are staggering. In Canada, outlays for ... be almost $2 billion per year. In a 5-year, ... to mothers who had entered premature labor led to ... the study are reported in the January issue of ...
... New predictions about bird flu, involving the use of ... antiviral drugs might be the best way to deal ... has not triggered a worldwide human epidemic yet because ... this ability, it would take 6-8 months to develop ...
Cached Biology News:Ocean's 'twilight zone' may be a key to understanding climate change 2
(Date:7/29/2015)... 29, 2015 Research ... addition of the "Global Biosimilars Market, 2015 ... The Global Biosimilars Market, 2015 - 2025, ... growing biosimilars market. With the blockbuster biologics losing ... costs, biosimilars are being viewed as viable substitutes ...
(Date:7/29/2015)... 2015  Therapath Neuropathology ( www.Therapath.com ), a ... VA and Military Medical centers both domestically and ... and Sweat Gland Nerve Fiber Density (SGNFD) for ... ). Demonstration of a reduction ... punch skin biopsy is a highly sensitive and ...
(Date:7/29/2015)... ... 2015 , ... The third Medical Innovation Impact Index (MI3) Alert considers FDA ... combinations. The current system received a score of 0 (range -10 to +10) for ... of Fairleigh Dickinson University’s ( FDU ) Rothman Institute of Innovation and Entrepreneurship. ...
(Date:7/29/2015)... , ... July 29, 2015 , ... Finding gooey or ... is quite normal. Although there are a considerable number of terms in popular use ... this post-sleep material is a mixture of mucus, blood cells, skin cells and dust, ...
Breaking Biology Technology:Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3Neuropathology services for VA and Military health systems 2Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 2Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 3What Are ‘Eye Crusties’ Made Of? uBiome Invites Citizen Scientists to Find Out 2What Are ‘Eye Crusties’ Made Of? uBiome Invites Citizen Scientists to Find Out 3What Are ‘Eye Crusties’ Made Of? uBiome Invites Citizen Scientists to Find Out 4
... Actavis Group, the,international generic pharmaceuticals company, has received ... & Drug,Administration. Distribution of the product will begin ... to Pfizer,s,Camptosar(R) will be available in 40 mg/2 ... is,used in the treatment of patients with metastatic ...
... Robert G. Johnson, Jr. Resigns as President and ... Near-Term Commercial Opportunities, HAYWARD, Calif., Feb. 28 ... announced that Robert G. Johnson, Jr.,M.D., Ph.D., has ... a,member of Kosan,s Board of Directors. Helen S. ...
... Arthrosurface, Inc.,( http://www.arthrosurface.com ), the developer of less-invasive ... approximately $4,million in its latest Preferred Stock Series ... private investors, to date, the company has,raised approximately ... funding,is earmarked to support our new product launches, ...
Cached Biology Technology:Actavis Receives Approval for Irinotecan Hydrochloride Injection; Extends US Portfolio with First Injectable Product 2Kosan Announces Senior Management Changes and Clinical Portfolio Priorities 2Kosan Announces Senior Management Changes and Clinical Portfolio Priorities 3Kosan Announces Senior Management Changes and Clinical Portfolio Priorities 4Kosan Announces Senior Management Changes and Clinical Portfolio Priorities 5Kosan Announces Senior Management Changes and Clinical Portfolio Priorities 6Kosan Announces Senior Management Changes and Clinical Portfolio Priorities 7Kosan Announces Senior Management Changes and Clinical Portfolio Priorities 8Arthrosurface Raises $4 Million of Preferred Equity Financing 2
6-(2,4-dinitrophenyl)aminohexanoic acid, succinimidyl ester (DNP-X, SE)...
...
X-Gal, 100 mg. 5-Bromo-4-chloro-3-indolyl-b-d-galactoside.Histochemical substrate for b-galactosidase, used in blue/white screening.Store at -20 C. Protect from moisture. Category: Nucleotides & Enzy...
...
Biology Products: